44th week of 2019 patent applcation highlights part 10 |
Patent application number | Title | Published |
20190328781 | MANUFACTURING METHODS FOR CELL-BASED THERAPEUTIC COMPOSITIONS | 2019-10-31 |
20190328782 | Dosing Regimen for Treatment of Cognitive and Motor Impairments with Blood Plasma and Blood Plasma Products | 2019-10-31 |
20190328783 | A METHOD OF ENGINEERING PRODRUG-SPECIFIC HYPERSENSITIVE T-CELLS FOR IMMUNOTHERAPY BY GENE EXPRESSION | 2019-10-31 |
20190328784 | CHIMERIC ANTIGEN RECEPTORS (CARS) SPECIFIC FOR MUC1 AND METHODS FOR THEIR USE | 2019-10-31 |
20190328785 | FLT3-BINDING CHIMERIC ANTIGEN RECEPTORS, CELLS, AND USES THEREOF | 2019-10-31 |
20190328786 | METHODS AND COMPOSITIONS FOR USE OF THERAPEUTIC T CELLS IN COMBINATION WITH KINASE INHIBITORS | 2019-10-31 |
20190328787 | T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR | 2019-10-31 |
20190328788 | THERAPEUTIC PEPTIDES THAT TARGET TGF-BETA INTERACTION | 2019-10-31 |
20190328789 | COMPOSITIONS FOR BIOLOGICAL SYSTEMS AND METHODS FOR PREPARING AND USING THE SAME | 2019-10-31 |
20190328790 | CELL-EMBEDDED BEADS FOR HAIR REGENERATION AND METHOD FOR PRODUCING SAME, AND KIT FOR HAIR REGENERATION | 2019-10-31 |
20190328791 | ENHANCED HETATOPOIETIC STEM CELL TRANSPLANTATION | 2019-10-31 |
20190328792 | MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLES AND THEIR MEDICAL USE | 2019-10-31 |
20190328793 | COMBINATION THERAPY FOR A STABLE AND LONG TERM ENGRAFTMENT | 2019-10-31 |
20190328794 | LIQUID AMNION TRANSPLANT PRODUCT | 2019-10-31 |
20190328795 | METHODS AND MATERIALS FOR TREATING LUNG DISORDERS | 2019-10-31 |
20190328796 | IMMUNITY GENERATION | 2019-10-31 |
20190328797 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES, COMPRISING BACTEROIDES ACIDIFACIENS AS ACTIVE INGREDIENT | 2019-10-31 |
20190328798 | MODULATION OF IMMUNE FUNCTION BY BACILLUS COAGULANS | 2019-10-31 |
20190328799 | USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF PSORIASIS | 2019-10-31 |
20190328800 | GENE EXPRESSION CASSETTE AND EXPRESSION VECTOR INCLUDING THE SAME | 2019-10-31 |
20190328801 | MICROORGANISM FOR DELIVERING DRUG FOR TREATMENT OF GASTROINTESTINAL DISEASE, WHICH EXPRESSES AND SECRETES P8 PROTEIN, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING GASTROINTESTINAL DISEASE, WHICH INCLUDES THE SAME | 2019-10-31 |
20190328802 | COMPOSITIONS AND METHODS FOR COMMON COLDS | 2019-10-31 |
20190328803 | NOVEL VIBRIO PARAHAEMOLYTICUS BACTERIOPHAGE VIB-PAP-4 AND USE THEREOF IN INHIBITING PROLIFERATION OF VIBRIO PARAHAEMOLITICUS BACTERIA | 2019-10-31 |
20190328804 | AAV Vectors Targeted to Oligodendrocytes | 2019-10-31 |
20190328805 | METHODS AND MATERIALS FOR TREATING CANCER | 2019-10-31 |
20190328806 | Nozzles for Essential Element Extraction Method and Apparatus | 2019-10-31 |
20190328807 | TOBACCO PRODUCTS WITH CANNABINOID ADDITIVES AND METHODS FOR REDUCING THE HARM ASSOCIATED WITH TOBACCO USE | 2019-10-31 |
20190328808 | PHARMACEUTICAL COMPOSITION COMPRISING MAPLE LEAF EXTRACT FOR PREVENTING OR TREATING RETINAL DISEASE | 2019-10-31 |
20190328809 | Method and Compositions for Treating Viral Infection | 2019-10-31 |
20190328810 | CHINESE MEDICINAL COMPOSITION FOR PREVENTING OR TREATING CARDIOVASCULAR AND CEREBROVASCULAR DISEASES OR DEMENTIA, AND PREPARATION METHOD AND USE THEREOF | 2019-10-31 |
20190328811 | INHIBITION OF FORMATION OF AMYLOID B-PROTEIN FIBRILS USING CACTUS MUCILAGE EXTRACTS | 2019-10-31 |
20190328812 | METHOD FOR ALLEVIATING ULTRAVIOLET DAMAGE WITH ETHYL ACETATE-EXTRACTED PRODUCT OF SEDUM FORMOSANUM | 2019-10-31 |
20190328813 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING TUMOURS, PREPARATION METHOD THEREFOR AND USE THEREOF | 2019-10-31 |
20190328814 | Anti-inflammatory, Analgesic and Fast-healing External Traditional Chinese Medicine Preparation and Its Preparation Method | 2019-10-31 |
20190328815 | SKIN CARE TREATMENT | 2019-10-31 |
20190328816 | Chinese medicinal composition that expels parasitic Toxoplasma gondii and a method of preparing the same | 2019-10-31 |
20190328817 | TRADITIONAL CHINESE MEDICINE HEALTHCARE PREPARATION FOR FAT ELIMINATION AND WEIGHT REDUCTION | 2019-10-31 |
20190328818 | COMPOSITIONS FOR WEIGHT LOSS | 2019-10-31 |
20190328819 | USE OF EXTRACTS OF DESCHAMPSIA ANTARCTICA FOR COUNTERACTING HUMAN SKIN BARRIER DAMAGE CAUSED BY ENVIRONMENTAL AGGRESSIONS | 2019-10-31 |
20190328820 | COMPOSITION COMPRISING A PLANT EXTRACT OF THE SPECIE HEDYCHIUM CORONARIUM, FOR USE IN A METHOD FOR TREATMENT OF THE HUMAN BODY BY THERAPY | 2019-10-31 |
20190328821 | METHODS FOR REDUCING OXIDATIVE DAMAGE | 2019-10-31 |
20190328822 | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY | 2019-10-31 |
20190328823 | COMPOSITION COMPRISING PROTEIN PHOSPHATASE 1 INHIBITORY PEPTIDE FOR TREATING VASCULAR DISEASES | 2019-10-31 |
20190328824 | HYDROGEL COMPOSITION AND ASSOCIATED METHOD OF USE | 2019-10-31 |
20190328825 | METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS | 2019-10-31 |
20190328826 | COMPOSITIONS AND METHODS FOR TREATING CANCER AND PERSISTENT VIRAL INFECTIONS | 2019-10-31 |
20190328827 | ANGIOTENSIN II ALONE OR IN COMBINATION FOR THE TREATMENT OF HYPOTENSION | 2019-10-31 |
20190328828 | PHARMACEUTICAL COMPOSITION, PROCESS FOR PRODUCING THE SAME, USE OF A PEPTIDE, USE OF A PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DISEASES ASSOCIATED WITH INTRAOCULAR HYPERTENSION OR GLAUCOMA | 2019-10-31 |
20190328829 | TRIPARTITE COMBINATION THERAPY FOR PROSTATE CANCER | 2019-10-31 |
20190328830 | Compositions and Methods for Treatment of Social Dysfunction Disorders | 2019-10-31 |
20190328831 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | 2019-10-31 |
20190328832 | ANTIMICROBIAL COMBINATIONS | 2019-10-31 |
20190328833 | POLYMYXIN-ALGINATE OLIGOMER CONJUGATES | 2019-10-31 |
20190328834 | ARTHROFACTIN FOR THE TREATMENT OF ACNE | 2019-10-31 |
20190328835 | MEANS AND METHODS FOR TREATING COPPER-RELATED DISEASES | 2019-10-31 |
20190328836 | METHODS FOR TREATING ISCHEMIC INJURY | 2019-10-31 |
20190328837 | Ciliary Neurotrophic Factor Receptor Ligands and Methods of Using the Same | 2019-10-31 |
20190328838 | COMPOSITIONS COMPRISING IL-2 FUSION PROTEINS AND METHODS FOR TREATING NEOPLASIA | 2019-10-31 |
20190328839 | Treatment of Type 1 Diabetes and Other Conditions Using the Gut Microbiome | 2019-10-31 |
20190328840 | CONTROLLED-RELEASE CNP AGONISTS WITH LOW INITIAL NPR-B ACTIVITY | 2019-10-31 |
20190328841 | CONTROLLED-RELEASE CNP AGONISTS WITH REDUCED SIDE-EFFECTS | 2019-10-31 |
20190328842 | COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN AGONIST RECEPTOR OR AN AMYLIN ANALOGUE AND A CO-POLYAMINO ACID | 2019-10-31 |
20190328843 | Calcitonin Analogues for Treating Diseases and Disorders | 2019-10-31 |
20190328844 | NANOPARTICLES FOR THE THERAPEUTIC TREATMENT OF RADIATION-INDUCED SKIN ULCERS | 2019-10-31 |
20190328845 | IN VIVO SYNTHESIS OF ELASTIC FIBER | 2019-10-31 |
20190328846 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RETINAL DEGENERATIVE DISEASES | 2019-10-31 |
20190328847 | MATERIALS AND METHODS USEFUL FOR TREATING GLIOBLASTOMA | 2019-10-31 |
20190328848 | METHOD FOR PREVENTING AND TREATING DRUG-INDUCED RENAL INJURY | 2019-10-31 |
20190328849 | METHOD AND DRUG FOR PREVENTING AND TREATING OBESITY | 2019-10-31 |
20190328850 | METHOD FOR PREVENTING AND TREATING LIPID METABOLISM DISORDERS AND RELATED DISEASES THEREOF | 2019-10-31 |
20190328851 | Stabilised Solid Compositions of Factor VII Polypeptides | 2019-10-31 |
20190328852 | METHODS FOR TREATMENT OF DISEASES | 2019-10-31 |
20190328853 | COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HOOF AND CLAW DISEASES | 2019-10-31 |
20190328854 | C5 IMMUNIZATION FOR AUTOLOGOUS ANTI-C5 ANTIBODY PRODUCTION | 2019-10-31 |
20190328855 | Optimized Synthetic Consensus Immunogenic Compositions Targeting Fibroblast Activation Protein | 2019-10-31 |
20190328856 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS | 2019-10-31 |
20190328857 | CALR AND JAK2 VACCINE COMPOSITIONS | 2019-10-31 |
20190328858 | EIMERIA VACCINE WITH IMPROVED EFFICACY | 2019-10-31 |
20190328859 | CLOSTRIDIUM DIFFICILE ANTIGENS | 2019-10-31 |
20190328860 | CHOLERA TOXIN CHIMERA AND ITS USE AS A STAPH VACCINE | 2019-10-31 |
20190328861 | MICROPARTICLES FROM STREPTOCOCCUS PNEUMONIAE AS VACCINE ANTIGENS | 2019-10-31 |
20190328862 | Stable, Spray Dried, Immunogenic, Viral Compositions | 2019-10-31 |
20190328863 | RECOMBINANT VIRUS, COMPOSITION COMPRISING THE SAME, AND USES THEREOF | 2019-10-31 |
20190328864 | HIV VACCINATION COMPOSITIONS | 2019-10-31 |
20190328865 | IMMUNOGENIC COMPOSITION FOR MERS CORONAVIRUS INFECTION | 2019-10-31 |
20190328866 | PURIFICATION OF HERPES VIRUS | 2019-10-31 |
20190328867 | Specific Binding Agents to Varicella-Zoster Virus and Uses Related Thereto | 2019-10-31 |
20190328868 | HERPES ZOSTER VACCINE COMPOSITION | 2019-10-31 |
20190328869 | IMMUNOTHERAPEUTIC PRODUCT AND MDSC MODULATOR COMBINATION THERAPY | 2019-10-31 |
20190328870 | ADJUVANT COMPOSITION AND USE THEREOF | 2019-10-31 |
20190328871 | MICROMOLDED OR 3-D PRINTED PULSATILE RELEASE VACCINE FORMULATIONS | 2019-10-31 |
20190328872 | Viral Vector Constructs for Expression of Genetic Adjuvants Activating the STING Pathway | 2019-10-31 |
20190328873 | VACCINES FOR USE IN TREATING VARIOUS DISEASES AND DISORDERS | 2019-10-31 |
20190328874 | COMPOSITIONS AND METHODS OF MODULATING ANTI-TUMOR IMMUNITY | 2019-10-31 |
20190328875 | ETANERCEPT FORMULATIONS STABILIZED WITH MEGLUMINE | 2019-10-31 |
20190328876 | SELECTIVE REMOVAL OF AGE-MODIFIED CELLS FOR TREATMENT OF ATHEROSCLEROSIS | 2019-10-31 |
20190328877 | Constructs, Agents, and Methods for Facilitated Ablation of Cardiac Tissue | 2019-10-31 |
20190328878 | LIGHT ACTIVATED GASOTRANSMITTER GENERATING COMPOSITIONS | 2019-10-31 |
20190328879 | CONSUMABLE ALCOHOLIC DRINK COMPOSITIONS CONTAINING AQUEOUS EMULSIFIED CANNABINOIDS | 2019-10-31 |
20190328880 | AMPHIPHILIC BLOCK COPOLYMER COMPOSITION HAVING ENHANCED MICELLE STABILITY, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 2019-10-31 |